Lyka Labs · NSE: LYKALABS · BSE: 500259
Q3 FY21 results · Oct–Dec 2020
Lyka Labs reported revenue from operations of ₹26.81 crore (up 46.1% from Q3 FY20) and net loss of ₹1.86 crore for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 26.81 | 18.36 | +46.1% | 17.46 | +53.6% |
| Other income | 0.28 | 0.93 | −69.2% | 0.36 | −21.5% |
| Total income | 27.10 | 19.28 | +40.5% | 17.82 | +52.1% |
| Profit before tax | (1.99) | (40.75) | Loss narrowed | (5.36) | Loss narrowed |
| Net profit for the period | (1.86) | (40.91) | Loss narrowed | (5.72) | Loss narrowed |
| EPS, basic (₹) | (0.80) | (14.50) | Loss narrowed | (2.01) | Loss narrowed |
| Net margin (%) | -6.9 | -222.9 | -32.8 |
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 18.91 | 10.05 | +88.1% | 12.10 | +56.3% |
| Other income | 0.40 | 0.72 | −45.1% | 0.44 | −10.6% |
| Total income | 19.31 | 10.77 | +79.2% | 12.55 | +53.9% |
| Profit before tax | (3.21) | (40.35) | Loss narrowed | (5.17) | Loss narrowed |
| Net profit for the period | (3.06) | (40.46) | Loss narrowed | (5.13) | Loss narrowed |
| EPS, basic (₹) | (1.80) | (14.24) | Loss narrowed | (1.80) | Unchanged |
| Net margin (%) | -16.2 | -402.5 | -42.4 |
Consolidated
- Filed with BSE
- 11 Feb 2021, 19:42 IST
- Board meeting
- 11 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Feb 2021, 19:42 IST
- Board meeting
- 11 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE